ADAMTS13 and thrombotic thrombocytopenic purpura: Potential interpretation bias should not be excluded: the initial increase and plateau could be due to the analysis by the laboratory of patients samples previously identified as TTP but for whom no ADAMTS-13 assay had been performed until 2016.